Renal · Year 2 · from Renal

Case 2: ACE Inhibitor-Associated Complications

Patient Presentation

Demographics: 74-year-old female

Chief Complaint: Dry cough and elevated creatinine

History of Present Illness: The patient was started on lisinopril 10 mg daily 3 weeks ago for hypertension with diabetic nephropathy. She has developed a persistent dry cough that keeps her awake at night. Additionally, her creatinine has risen from 1.4 to 1.9 mg/dL. Her potassium is now 5.4 mEq/L.

Past Medical History:

  • Type 2 diabetes mellitus with nephropathy
  • Hypertension
  • Peripheral vascular disease

Current Medications:

  • Lisinopril 10 mg daily (new)
  • Amlodipine 5 mg daily
  • Metformin 1000 mg twice daily
  • Atorvastatin 40 mg daily

Physical Examination:

  • Blood pressure: 148/82 mmHg
  • Heart rate: 72 bpm
  • Lungs: Clear (no wheezing)
  • Cardiovascular: Regular, bilateral femoral bruits
  • No edema

Workup and Results

Laboratory Studies (Baseline vs Current):

  • Creatinine: 1.4 → 1.9 mg/dL (36% increase)
  • Potassium: 4.6 → 5.4 mEq/L
  • BUN: 22 → 32 mg/dL

Renal Ultrasound with Doppler:

  • Right kidney 9 cm, left kidney 10 cm
  • Elevated resistive indices bilaterally
  • Cannot exclude renal artery stenosis

Clinical Image

Diagram showing how ACE inhibitors cause efferent arteriolar dilation, reducing intraglomerular pressure. In bilateral renal artery stenosis, this compensatory mechanism is essential for maintaining GFR, and its blockade causes acute kidney injury.

Diagnosis

ACE Inhibitor-Related Complications:

  1. ACE inhibitor cough (bradykinin-mediated)
  2. AKI likely secondary to bilateral renal artery stenosis
  3. Hyperkalemia

Discussion

This case illustrates ACE inhibitor pharmacology:

  • Cough Mechanism: The lecture describes how ACE inhibitor cough is due to bradykinin accumulation (ACE breaks down bradykinin). This occurs in 5-20% of patients and is not seen with ARBs.
  • Renoprotective Mechanism: The lecture explains that ACE inhibitors reduce intraglomerular pressure by blocking efferent arteriolar constriction mediated by angiotensin II. This is beneficial for diabetic nephropathy.
  • Bilateral RAS Contraindication: The lecture emphasizes that ACE inhibitors are contraindicated in bilateral renal artery stenosis. When renal perfusion is compromised, angiotensin II-mediated efferent constriction is essential to maintain GFR.
  • Acceptable Creatinine Rise: The lecture states that a creatinine rise up to 30% is acceptable after starting ACE inhibitors. This patient's 36% rise exceeds this threshold and warrants further evaluation.

Treatment Plan

  1. Discontinue Lisinopril:
  • Cough should resolve within 1-4 weeks
  • Creatinine should improve
  1. Evaluate for Renal Artery Stenosis:
  • CT angiography or MRA
  • Consider revascularization if significant stenosis
  1. Alternative Antihypertensive:
  • If no significant RAS: Can try ARB (no cough)
  • If bilateral RAS confirmed: Avoid all RAAS blockers
  • Consider calcium channel blocker or beta-blocker
  1. Monitor:
  • Repeat creatinine and potassium in 1 week
  • Watch for hyperkalemia

Teaching Points

  1. ACE inhibitor cough is bradykinin-mediated; switch to ARB if cough intolerable
  2. Acceptable creatinine rise after ACE inhibitor is up to 30%
  3. ACE inhibitors are contraindicated in bilateral renal artery stenosis
  4. Peripheral vascular disease is a risk factor for renal artery stenosis
  5. RAAS blockade reduces proteinuria and slows diabetic nephropathy progression

All cases for this lecture as Markdown